44 results on '"Pearson, Robert R"'
Search Results
2. GaN Unleashed: The Benefits of Microfluidic Cooling
3. Differences in emotional functioning across drinking classes
4. Risk of Nephropathy Is Not Increased by the Administration of Larger Volume of Contrast During Coronary Angiography
5. Exceptional Mortality Prediction by Risk Scores from Common Laboratory Tests
6. Superior predictive ability for death of a basic metabolic profile risk score
7. Fasting and Other Health Influences
8. Usefulness of Routine Periodic Fasting to Lower Risk of Coronary Artery Disease in Patients Undergoing Coronary Angiography
9. Comparison of Effects of Simvastatin Alone Versus Fenofibrate Alone Versus Simvastatin Plus Fenofibrate on Lipoprotein Subparticle Profiles in Diabetic Patients With Mixed Dyslipidemia (from the Diabetes and Combined Lipid Therapy Regimen Study)
10. Abstract 3532: Lipoprotein-Associated Phospholipase A 2 and High Sensitivity C-Reactive Protein Levels and the Prediction of Cardiovascular Risk Among Coronary Artery Disease Patients With Differing Clinical Presentations
11. Surgical Revascularization Is Associated With Improved Long-Term Outcomes Compared With Percutaneous Stenting in Most Subgroups of Patients With Multivessel Coronary Artery Disease
12. Soluble CD40 Ligand as a Predictor of Coronary Artery Disease and Long-Term Clinical Outcomes in Stable Patients Undergoing Coronary Angiography
13. Spotted Owls, Barred Owls, and Late-Successional Reserves
14. Comparison of Effects of High (80 mg) Versus Low (20 mg) Dose of Simvastatin on C-Reactive Protein and Lipoproteins in Patients With Angiographic Evidence of Coronary Arterial Narrowing
15. Lipoprotein-associated phospholipase A2 independently predicts the angiographic diagnosis of coronary artery disease and coronary death
16. The Reduction of Inflammatory Biomarkers by Statin, Fibrate, and Combination Therapy Among Diabetic Patients With Mixed Dyslipidemia
17. Candidate gene susceptibility variants predict intermediate end points but not angiographic coronary artery disease
18. Improved long-term survival associated with stent deployment during percutaneous coronary interventions: Results from a registry of 3399 patients
19. Do Statins Increase the Risk of Idiopathic Polyneuropathy?
20. Serum Uric Acid Independently Predicts Mortality in Patients with Significant, Angiographically Defined Coronary Disease
21. Early effects of statins in patients with coronary artery disease and high C-reactive protein
22. Improvements in 1-Year Cardiovascular Clinical Outcomes Associated with a Hospital-Based Discharge Medication Program
23. 810-5 Use of either metformin or thiazolidinedione is associated with improved survival among patients with type 2 diabetes from a registry of 16,203 diabetic patients
24. Which Features of the Metabolic Syndrome Predict the Prevalence and Clinical Outcomes of Angiographic Coronary Artery Disease?
25. Effect of fasting glucose levels on mortality rate in patients with and without diabetes mellitus and coronary artery disease undergoing percutaneous coronary intervention
26. Which lipid/lipoprotein ratio best predicts angiographic coronary artery disease?
27. Which features of the metabolic syndrome predict the presence of angiographic coronary artery disease?
28. Short-term therapy with gatifloxacin or azithromycin prevents the acceleration of atherosclerosis after infection with Chlamydia Pneumoniaein a rabbit model but does not eradicate the organism form plaque
29. Troponin-I and C-reactive protein have independent value for prediction of long-term risk after acute coronary syndromes: Utility of troponin-I is increased for women
30. Do statins provide clinical benefit in high-risk coronary artery disease patients with advanced left ventricular dysfunction?
31. Low socioeconomic status is more predictive of increased hazard in women than men after angiographic diagnosis of coronary artery disease
32. Polymorphisms of the CETP, ABC, MTHFR, LPL, and PAI-1 genes predict intermediate endpoints but not angiographic coronary disease: Implications for genetic research
33. Primary use of the cutting balloon results in fewer major adverse cardiovascular events at six months than balloon angioplasty in a subgroup of patients with ostial/bifurcation or small vessel lesions
34. Angiotensin converting enzyme inhibition reduces elevated C-reactive protein in patients with angiographic coronary artery disease
35. Which features of the metabolic syndrome predict clinical outcomes (death/myocardial infarction) in patients with angiographic coronary artery disease?
36. Statin therapy is associated with reduced mortality across all age groups of individuals with significant coronary disease, including very elderly patients
37. An institutional discharge medication program reduces future cardiovascular readmissions and mortality: an analysis of 43,841 patients with coronary artery disease
38. Inadequate prediction of death by the framingham risk model for patients with existing, angiographically- defined coronary artery disease
39. The intermountain risk model: predicting mortality by traditional and novel risk factors among patients with significant coronary disease
40. Cytomegalovirus Seropositivity and C-Reactive Protein Have Independent and Combined Predictive Value for Mortality in Patients With Angiographically Demonstrated Coronary Artery Disease
41. Randomized Secondary Prevention Trial of Azithromycin in Patients With Coronary Artery Disease
42. A common variant of the AMPD1 gene predicts improved cardiovascular survival in patients with coronary artery disease
43. Plasma Homocysteine Predicts Mortality Independently of Traditional Risk Factors and C-Reactive Protein in Patients With Angiographically Defined Coronary Artery Disease
44. Efficiency vs responsiveness in a multiple-services computer facility
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.